Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents.
Fritzinger
David C
DC
Natural Products and Cancer Biology Program, Cancer Research Center of Hawaii, USA.
D000818:Animals; D003167:Complement Activation; D003176:Complement C3 / Q000502:physiology*; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D004546:Elapid Venoms / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*
D003176:Complement C3; D003169:Complement Inactivator Proteins; D004546:Elapid Venoms; D011993:Recombinant Fusion Proteins